PRP injections may improve hair density in some people with male or female pattern hair loss, but the evidence does not show that PRP is clearly superior to topical minoxidil. Responses vary, and preparation and injection protocols are not standardized, so PRP is best considered an adjunct after the diagnosis and realistic goals have been established.prp-minoxidil-metaprp-review
What is PRP treatment for hair loss?
Platelet-rich plasma, or PRP, is made by drawing a person's blood, separating a platelet-enriched portion, and injecting it into the scalp. The rationale is that signaling proteins released by platelets may influence the environment around hair follicles.prp-review
Two treatments bearing the PRP name may not be equivalent. Blood volume, centrifugation steps, platelet concentration, white-cell content, activation method, injection depth, and treatment interval vary across clinics and studies. This variability is a major reason the results are difficult to compare.preparation-reviewprp-review
What the evidence says at a glance
| Question | Evidence-based answer |
|---|---|
| Can PRP increase hair growth? | Some randomized trials and reviews report improvements in hair count or density.alopecia-meta |
| Is PRP better than minoxidil? | A review of nine randomized trials found no clear PRP advantage in hair density, terminal hair count, or moderate-to-high regrowth.prp-minoxidil-meta |
| Are i-PRF or CGF better than PRP? | A 2026 trial in female pattern hair loss found larger target-area hair-count increases with i-PRF and CGF, but one study is not enough to generalize the result.fphl-trial |
| Can PRP replace standard treatment? | Current evidence supports viewing it as an adjunct rather than an established replacement.guidance |
The 2026 PRP, i-PRF, and CGF trial
A 2026 multicenter randomized trial assigned women with Sinclair grade II–III female pattern hair loss to PRP, injectable platelet-rich fibrin (i-PRF), or concentrated growth factors (CGF). Participants received four sessions at four-week intervals, and 74 completed the 24-week assessment.fphl-trial
Non-vellus target-area hair count increased from baseline in all three groups. The reported mean increases were 14.53% with PRP, 26.54% with i-PRF, and 27.11% with CGF. The i-PRF and CGF groups improved more than the PRP group on that outcome. Hair diameter improved in all groups without a statistically significant difference between groups, and i-PRF had the lowest reported adverse-event rate.fphl-trial
Important limitations keep this from being a final answer:
- Only 74 participants completed the study.
- The trial studied female pattern hair loss, so its results cannot simply be transferred to men.
- Follow-up lasted 24 weeks, leaving long-term durability uncertain.
- There was no untreated or minoxidil comparison group.
- Results from one preparation protocol may not apply to different devices or methods.
The appropriate conclusion is not that i-PRF or CGF is always better than PRP. It is that a new comparative result needs replication in larger, longer trials.
PRP compared with topical minoxidil
A systematic review and meta-analysis published online in 2025 included nine randomized trials and 451 participants with androgenetic alopecia. Some outcomes, including patient satisfaction and the hair-pull test, favored PRP. However, PRP did not show a clear advantage over topical minoxidil for hair density, terminal hair count, or moderate-to-high regrowth, and heterogeneity across studies was high.prp-minoxidil-meta
Topical minoxidil is used regularly at home, whereas PRP requires blood collection and scalp injections. A practical comparison should include cost, discomfort, clinic visits, and the feasibility of maintenance—not efficacy alone. See Understanding Minoxidil for a separate discussion of the medication.
How many PRP sessions are needed?
Research protocols often use three or four initial sessions followed by some form of maintenance, but there is no single universally accepted schedule for every patient.prp-reviewpreparation-review The latest female-pattern trial used four treatments at four-week intervals and assessed outcomes at 24 weeks; that research schedule is not a personalized prescription.fphl-trial
Before treatment, ask the clinician:
- whether the diagnosis is androgenetic alopecia;
- whether the product is PRP, i-PRF, or CGF;
- how the blood product and injection protocol are prepared;
- how outcomes will be measured with standardized photographs, counts, or hair diameter;
- the total cost of initial and maintenance sessions; and
- when treatment will be stopped if there is no objective improvement.
Side effects and precautions
Using a person's own blood does not make the procedure risk-free. Injection-site pain, tenderness, swelling, bruising, and temporary headache may occur. Because the skin is punctured, bleeding and infection also remain considerations.prp-reviewalopecia-meta
People taking anticoagulant or antiplatelet drugs, or those with a platelet or blood disorder, active scalp infection, or another significant illness, should discuss these issues with the treating clinician. Do not stop a prescribed medicine on your own. Pregnancy and breastfeeding also require an individualized discussion.
When PRP should not be the first step
Most PRP evidence concerns androgenetic alopecia. Sudden, patchy, painful, inflamed, scarring, or rapidly worsening hair loss needs diagnostic evaluation by a dermatologist first. Treating an undiagnosed condition with PRP alone may delay appropriate care.
Frequently asked questions
Is PRP an approved hair-loss drug?
PRP is a procedure that processes and reinjects a patient's blood; it is not a drug with one fixed ingredient and dose like finasteride or minoxidil. Regulatory status varies by country and by the equipment used, so ask the clinic what specifically is authorized.
Can one PRP session regrow hair?
Most clinical studies evaluated a series of treatments, not one injection. Evidence is insufficient to promise lasting regrowth from a single session.prp-review
Can PRP and minoxidil be used together?
Combination protocols have been studied, but combination treatment is not necessary for everyone. The decision should follow the diagnosis, prior response, scalp condition, and contraindications.prp-minoxidil-meta
Does PRP improve hair-transplant graft survival?
Studies have examined PRP alongside hair transplantation, but protocols vary and the evidence is not sufficiently standardized. Follow the transplant surgeon's recovery plan rather than arranging an additional procedure immediately after surgery.
Bottom line
PRP is a plausible adjunct for androgenetic alopecia, not a guaranteed cure. It has not shown a clear advantage over minoxidil on key regrowth outcomes, and evidence favoring i-PRF or CGF remains limited. Confirm the diagnosis, exact protocol, objective measurement plan, total cost, and stopping rule before proceeding.
- Umar M, et al. PRP versus topical minoxidil for androgenetic alopecia: a systematic review and meta-analysis. Aesthetic Plastic Surgery. Online 2025; print 2026.↩
- Hesseler MJ, Shyam N. Platelet-rich plasma and its utilities in alopecia: a systematic review. Dermatologic Surgery. 2020.↩
- Kramer ME, Keaney TC. Systematic review of PRP preparation and composition for androgenetic alopecia. Journal of Cosmetic Dermatology. 2018.↩
- Kaiser M, et al. Treatment of androgenetic alopecia: current guidance and unmet needs. Clinical, Cosmetic and Investigational Dermatology. 2023.↩
- Li M, et al. Comparative efficacy and safety of PRP, i-PRF and CGF for female pattern hair loss: a prospective multicenter randomized clinical trial. Journal of Dermatological Treatment. 2026.↩
- Cruciani M, et al. Platelet-rich plasma for the treatment of alopecia: a systematic review and meta-analysis. Blood Transfusion. 2023.↩